Clinical Program Director – Precision Oncology Diagnostics; MRD Focus

Labcorp is a global leader in laboratory services, providing the insights and answers that help healthcare providers, patients, researchers, pharmaceutical companies and health systems make confident decisions and improve outcomes. Through our unparalleled science, data, technology and laboratory network, we advance diagnostics, accelerate innovation and help address some of the world’s most important health challenges. As we shape the future of healthcare, we are leveraging advanced technologies, intelligent digital solutions and data‑driven innovation across our operations to enhance how work gets done and deliver greater value to customers and patients.

With our global scale and deep expertise, you’ll have the opportunity to do meaningful work, grow your career and make a real impact on people’s health around the world. Together, we’re improving health and improving lives.

Work Schedule:

Monday – Friday 8:00am – 5:00pm

This role exists to design, execute, and scale clinical development programs that demonstrate the clinical utility of precision oncology diagnostics, with an initial and primary focus on molecular residual disease (MRD) in solid tumors. The purpose of this position is to ensure that diagnostic‑driven evidence generation is tightly aligned with real‑world clinical decision‑making, guideline development, reimbursement needs, and long‑term portfolio strategy.

The individual in this role will be responsible for defining why specific diagnostic‑focused studies are needed (e.g., unmet clinical questions, evidence gaps for adoption or access) and how those studies should be operationalized across internal teams and external partners. While MRD will be the initial anchor, this will evolve alongside the precision oncology diagnostic portfolio to include broader solid tumor biomarkers, ctDNA and liquid biopsy applications, and integrated somatic and germline strategies.

This is both a strategic and hands‑on execution role, reporting to the Senior Director of Medical Affairs. Initially functioning as a senior individual contributor at the Director level, this position will have significant cross‑functional influence and is expected to help shape, formalize, and scale the future clinical development infrastructure for diagnostics and precision oncology as the organization grows.

• Evaluate the current precision oncology and diagnostic evidence landscape to identify gaps limiting clinical adoption, guideline inclusion, reimbursement, and commercial scalability.
• Define diagnostic‑focused clinical development priorities that demonstrate clear clinical utility, real‑world impact, and value of MRD and other precision oncology assays.
• Develop and articulate a clear business and clinical rationale for proposed studies, linking evidence generation to strategic objectives, portfolio differentiation, and downstream impact.
• Partner with cross functional teams, including medical affairs, market access, R&D, and commercial teams to ensure studies are designed to answer payer‑, provider‑, and health system‑relevant questions.
• Ensure alignment between diagnostic capabilities, intended clinical use, and evolving standards of care.

• Lead the development of clinical study concepts, objectives, and endpoints, with a strong emphasis on MRD, ctDNA, and solid tumor applications.
• Drive protocol development in collaboration with medical affairs, R&D, regulatory, operations, and external partners.
• Actively manage ongoing studies, including oversight of timelines, enrollment progress, data quality, and operational execution.
• Ensure studies are fit‑for‑purpose and adaptable as scientific and clinical understanding and portfolio needs evolve.

• Serve as a scientific and clinical subject matter expert for MRD landscape and diagnostic‑driven oncology studies in solid tumors.
• Lead and influence cross‑functional working groups across medical affairs, operations, regulatory,…